Literature DB >> 20865011

Kaposi's sarcoma and its associated herpesvirus.

Enrique A Mesri1, Ethel Cesarman, Chris Boshoff.   

Abstract

Kaposi's sarcoma (KS) is the most common cancer in HIV-infected untreated individuals. Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8 (HHV8)) is the infectious cause of this neoplasm. In this Review we describe the epidemiology of KS and KSHV, and the insights into the remarkable mechanisms through which KSHV can induce KS that have been gained in the past 16 years. KSHV latent transcripts, such as latency-associated nuclear antigen (LANA), viral cyclin, viral FLIP and viral-encoded microRNAs, drive cell proliferation and prevent apoptosis, whereas KSHV lytic proteins, such as viral G protein-coupled receptor, K1 and virally encoded cytokines (viral interleukin-6 and viral chemokines) further contribute to the unique angioproliferative and inflammatory KS lesions through a mechanism called paracrine neoplasia.

Entities:  

Mesh:

Year:  2010        PMID: 20865011      PMCID: PMC4721662          DOI: 10.1038/nrc2888

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  196 in total

1.  Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.

Authors:  Young C Shin; Chul-Hyun Joo; Michaela U Gack; Hye-Ra Lee; Jae U Jung
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

2.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Authors:  Qi Ma; Lucas E Cavallin; Bin Yan; Shoukang Zhu; Elda Margarita Duran; Huili Wang; Laura P Hale; Chunming Dong; Ethel Cesarman; Enrique A Mesri; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-08       Impact factor: 11.205

3.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  CGH of microdissected Kaposi's sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages.

Authors:  Pawan Pyakurel; Ulrike Montag; Esmeralda Castaños-Vélez; Ephata Kaaya; Birger Christensson; Holger Tönnies; Peter Biberfeld; Thomas Heiden
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

5.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo.

Authors:  Emmy W Verschuren; Juha Klefstrom; Gerard I Evan; Nic Jones
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

7.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

8.  The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients.

Authors:  Maria Gazouli; George Zavos; Ioannis Papaconstantinou; John C Lukas; Anastassios Zografidis; John Boletis; Alkiviadis Kostakis
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

9.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.

Authors:  Subhash C Verma; Sumit Borah; Erle S Robertson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  369 in total

1.  Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.

Authors:  Mel Campbell; Pei-Ching Chang; Steve Huerta; Chie Izumiya; Ryan Davis; Clifford G Tepper; Kevin Y Kim; Bogdan Shevchenko; Don-Hong Wang; Jae U Jung; Paul A Luciw; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

2.  Kaposi's sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation.

Authors:  Qiming Liang; Brian Chang; Kevin F Brulois; Kamilah Castro; Chan-Ki Min; Mary A Rodgers; Mude Shi; Jianning Ge; Pinghui Feng; Byung-Ha Oh; Jae U Jung
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.

Authors:  Jiadi Hu; Bruno C Jham; Tao Ma; Eitan R Friedman; Leticia Ferreira; John M Wright; Brent Accurso; Carl M Allen; John R Basile; Silvia Montaner
Journal:  Oral Oncol       Date:  2011-03-21       Impact factor: 5.337

4.  Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.

Authors:  Meilan He; Wei Zhang; Thomas Bakken; Melissa Schutten; Zsolt Toth; Jae U Jung; Parkash Gill; Mark Cannon; Shou-Jiang Gao
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

5.  Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.

Authors:  Penny M Anders; Nathan D Montgomery; Stephanie A Montgomery; Aadra P Bhatt; Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

6.  KSHV infection of B-cell lymphoma using a modified KSHV BAC36 and coculturing system.

Authors:  Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

7.  Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability.

Authors:  Jayaraju Dheekollu; Horng-Shen Chen; Kenneth M Kaye; Paul M Lieberman
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 8.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

Review 9.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 10.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.